Haematological Disease

Haematological Disease

Afficher d'autres versions (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Description complète

Détails bibliographiques
Auteurs principaux:	Estcourt, L, Stanworth, S, Murphy, M
Format:	Book section
Publié:	John Wiley and Sons 2013

Documents similaires

Haematological Disease
par: Murphy, M, et autres
Publié: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
par: Estcourt, L, et autres
Publié: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
par: Estcourt, L, et autres
Publié: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
par: Estcourt, L, et autres
Publié: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
par: Estcourt, L, et autres
Publié: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
par: Wardrop, D, et autres
Publié: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
par: Wardrop, D, et autres
Publié: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
par: Desborough, M, et autres
Publié: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
par: Estcourt, L, et autres
Publié: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
par: Estcourt, L, et autres
Publié: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
par: Estcourt, L, et autres
Publié: (2015)

Prophylactic platelet transfusions
par: Estcourt, L, et autres
Publié: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
par: Estcourt, L, et autres
Publié: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
par: Estcourt, L, et autres
Publié: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
par: Estcourt, L, et autres
Publié: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
par: Estcourt, L, et autres
Publié: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
par: Estcourt, L, et autres
Publié: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
par: Estcourt, L, et autres
Publié: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
par: Estcourt, L, et autres
Publié: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
par: Stanworth, S, et autres
Publié: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
par: Estcourt, L, et autres
Publié: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
par: Stanworth, S, et autres
Publié: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
par: Stanworth, S, et autres
Publié: (2014)

2016 National audit of red cell use in adult haematology patients
par: Karakantza, M, et autres
Publié: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
par: Crighton, GL, et autres
Publié: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
par: Butler, C, et autres
Publié: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
par: Crighton, GL, et autres
Publié: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
par: Estcourt, L, et autres
Publié: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
par: Estcourt, L, et autres
Publié: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
par: Butler, C, et autres
Publié: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
par: Butler, C, et autres
Publié: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
par: Murphy, M, et autres
Publié: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
par: Hyde, C, et autres
Publié: (2008)

Evidence for indications of fresh frozen plasma.
par: Stanworth, S, et autres
Publié: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
par: Hyde, C, et autres
Publié: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
par: Campbell, H, et autres
Publié: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
par: Campbell, H, et autres
Publié: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
par: Estcourt, L, et autres
Publié: (2012)

Alternatives to allogeneic platelet transfusion
par: Desborough, M, et autres
Publié: (2016)

Putting clinical trials into context.
par: Hyde, C, et autres
Publié: (2005)